Usefulness of The C‐Reactive Protein/Albumin Ratio for Predicting No‐Reflow in ST‐elevation myocardial infarction treated with primary percutaneous coronary intervention
European Journal of Clinical Investigation2018Vol. 48(6), pp. e12928–e12928
Citations Over TimeTop 10% of 2018 papers
Yavuz Karabağ, Metin Çağdaş, İbrahim Rencüzoğulları, Süleyman Karakoyun, İnanç Artaç, Doğan İliş, Mahmut Yesın, Öznur Sadioğlu Çağdaş, Bernas Altıntaş, Cengiz Burak, İbrahi̇m Hali̇l Tanboğa
Abstract
No-reflow can be predicted by systemic inflammation markers including WBC count, NLR and CAR measured from the blood sample obtained on admission. CAR has a higher clinical value than CRP, albumin level, WBC count and NLR in NR prediction.
Related Papers
- Are serum inflammatory markers age dependent in acute appendicitis?(1997)
- → The role of C-reactive protein and white blood cell count in the prediction of length of stay in hospital and severity of odontogenic abscess(2018)38 cited
- → CRT-107 Neutrophil to Lymphocyte Ratio Predicts Short Term Mortality (30 Days) in Patients Undergoing Primary Percutaneous Coronary Intervention Due to Acute ST Segment Elevation Myocardial Infarction(2014)
- Relationship between C-reactive protein and white blood cell in chidren with acute bacterial infection(2007)
- → The value of detection of C-reactive protein for the diagnosis and treatment of pediatric diseases(2011)